Merkel cell carcinoma (MCC) is a rare type of skin cancer. It starts in the Merkel cells, which are usually in the top layer of the skin. This layer is called the epidermis. Merkel cells are near the ...

HURA READ THE FULL HURA RESEARCH REPORT Operational and Financial Results On April 1 st , 2025, TuHURA Biosciences, Inc.

A phase 1b trial is evaluating PH-762 for the treatment of cutaneous squamous cell carcinoma, melanoma and Merkel cell ...

The Merkel cell carcinoma market is poised for steady growth, with a strong CAGR projected from 2024 to 2034. This expansion across the 7MM will be driven by the launch of innovative therapies ...

The detection of metastases in Merkel cell carcinoma (MCC) requires additional testing, such as pancytokeratin (panCK) or CK20, with no guarantee of success. Recent findings have identified ...

Researchers studied trends in survival following FDA approval of immune checkpoint inhibitors among patients with advanced Merkel cell carcinoma.

Medically reviewed by Casey Gallagher, MD Skin cancer occurs when skin cells mutate and grow uncontrollably. The most common cause of skin cancer is cell damage from the sun’s ultraviolet (UV) rays.

Phio Pharmaceuticals announces Safety Monitoring Committee recommendation to advance INTASYL PH-762 skin cancer study: Marlborough, Massachusetts Saturday, April 12, 2025, 15:00 H ...

A new systematic review reveals promising results for oncolytic viral therapy in treating nonmelanoma skin cancers and ...

Phio Pharmaceuticals stock rallies as safety committee gives green light to advance skin cancer candidate to next dose concentration in phase I study.